ABSTRACT
The ability of a photosensitizer to partition into membrane is determined by its structure and physical properties. Partitioning behavior can be quantitated as the partition coefficient (Kp) for a particular drug. This property may be an important determinant of cytocidal efficacy in photodynamic therapy. The Kp of five photoactive drugs--13,17-ditetraammonium protoporphyrin (PH1008), photofrin II (PII), hematoporphyrin (Hp), benzoporphyrin derivative monoacid (BPD-MA), coproporphyrin (Cp), and uroporphyrin (Up)--was determined using a simple liposome system composed of sonicated egg phosphatidylcholine single bilayer vesicles. The cytocidal efficacy of each drug was compared by determining the concentration of drug resulting in 50% maximal lysis (C50) obtained by measuring the hemoglobin absorbance at 414 nm released from lysed human red blood cells. The percentage lysis at 1 microM final drug concentration was also determined. An argon-dye laser was used to administer light of 630-nm wavelength for a total exposure of 5 J/cm2. Porphyrins with a greater tendency to partition into phosphocholine bilayer membranes demonstrated a greater lytic efficacy in the rbc system utilized. The comparison of physical properties with lytic ability may be useful in understanding the mechanism by which PDT exerts its effects and in predicting the clinical efficacy of different drugs.
Subject(s)
Laser Therapy , Photochemotherapy , Porphyrins/pharmacology , Radiation-Sensitizing Agents/pharmacology , Cell Membrane/drug effects , Cell Membrane/metabolism , Coproporphyrins/administration & dosage , Coproporphyrins/metabolism , Coproporphyrins/pharmacology , Dihematoporphyrin Ether , Erythrocytes/drug effects , Erythrocytes/metabolism , Hematoporphyrin Photoradiation , Hematoporphyrins/administration & dosage , Hematoporphyrins/metabolism , Hematoporphyrins/pharmacology , Hemoglobins/metabolism , Hemolysis/drug effects , Humans , Phosphatidylcholines/metabolism , Porphyrins/administration & dosage , Porphyrins/metabolism , Protoporphyrins/pharmacology , Radiation-Sensitizing Agents/metabolism , Uroporphyrins/administration & dosage , Uroporphyrins/metabolism , Uroporphyrins/pharmacologyABSTRACT
14C-labelled coproporphyrin I and III and uroporphyrin I were injected intravenously into healthy human subjects. Two experiments were performed with each porphyrin. Counting of blood, urine and faeces was made as a function of time. The coproporphyrin data were simulated by means of an analogy computer by using a four-compartment model with a delay pool. The physiological counterparts to the compartments were considered to be liver, blood and gut. From the blood radioactivity disappearance curve of uroporphyrin three exponential components could be worked out. The least square method was used for the solution of the plasma and urine radioactivity curves. A three-compartment model was constructed to illustrate the kinetics of uroporphyrin I. Coproporphyrin I and III behaved essentially similarly, whilst the kinetic behaviour of uroporphyrin I was completely different from that of coproporphyrins. A rapid hepatic uptake, preferential faecal excretion and a significant enterohepatic circulation were features of coproporphyrin kinetics. Over 70 per cent of the tracer activity of uroporphyrin I was found to accumulate to a rather large pool (volume 16--28 times the plasma volume) from where the back flow to plasma was rather slow. Practically all the uroporphyrin was excreted via urine.
